Decoy Therapeutics (DCOY) Research & Development (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Research & Development of $749813.0 for Q1 2026, up 892.71% year-over-year from $75532.0 in Q1 2025, and up 555.26% quarter-over-quarter from $114429.0 in Q4 2025.
Decoy Therapeutics (DCOY) Research & Development (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Research & Development for 12 consecutive years, with $749813.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 892.71% year-over-year to $749813.0; the TTM figure through Mar 2026 stood at $1.0 million (up 722.47% YoY), while the FY2025 annual figure was $368170.0, changed N/A from the prior year.
- Research & Development climbed to $749813.0 in Q1 2026 per DCOY's latest filing, from $114429.0 in the prior quarter.
- Across five years, Research & Development topped out at $4.7 million in Q4 2022 and bottomed at -$594683.0 in Q4 2024.
- Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $243002.0 in 2024.
- Annual changes were most pronounced in 2024 — Research & Development slumped 1091.92% — and 2026, when it jumped 892.71%.
- Decoy Therapeutics' Research & Development stood at $4.7 million in 2022, then sank by 98.72% to $59953.0 in 2023, then plunged by 1091.92% to -$594683.0 in 2024, then soared by 119.24% to $114429.0 in 2025, then jumped by 555.26% to $749813.0 in 2026.
- Business Quant data shows DCOY's Research & Development at $749813.0 in Q1 2026, $114429.0 in Q4 2025, and $61826.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 651.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 612.28 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 413.13 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 210.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 97.90 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -588.31 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 749,813.00 |
| Dec 31, 2025 | 114,429.00 |
| Sep 30, 2025 | 61,826.00 |
| Jun 30, 2025 | 116,383.00 |
| Mar 31, 2025 | 75,532.00 |
| Dec 31, 2024 | -594,683.00 |
| Sep 30, 2024 | 137,234.00 |
| Jun 30, 2024 | 214,447.00 |
| Mar 31, 2024 | 243,002.00 |
| Dec 31, 2023 | 59,953.00 |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 3.73 Mn |
| Dec 31, 2022 | 4.69 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 2.92 Mn |
| Mar 31, 2022 | 4.44 Mn |
| Dec 31, 2021 | 2.70 Mn |
| Sep 30, 2021 | 2.02 Mn |